Publication:
Is (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?

Simple item page
dc.contributor.authorRouzé, Anahita
dc.contributor.authorEstella, Ángel
dc.contributor.authorTimsit, Jean-François
dc.date.accessioned2023-05-03T13:26:39Z
dc.date.available2023-05-03T13:26:39Z
dc.date.issued2022-06-30
dc.identifier.doi10.1007/s00134-022-06766-2
dc.identifier.essn1432-1238
dc.identifier.pmid35771251
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s00134-022-06766-2.pdf
dc.identifier.urihttp://hdl.handle.net/10668/19586
dc.issue.number7
dc.journal.titleIntensive care medicine
dc.journal.titleabbreviationIntensive Care Med
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.organizationAGS - Jerez, Costa Noroeste y Sierra de Cáidz
dc.page.number930-932
dc.pubmedtypeEditorial
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshAntifungal Agents
dc.subject.meshGlucans
dc.subject.meshHumans
dc.subject.meshIntensive Care Units
dc.subject.meshProteoglycans
dc.subject.meshbeta-Glucans
dc.titleIs (1,3)-β-D-glucan useless to guide antifungal therapy in ICU?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number48
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario de Jerez de la Frontera

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía